Evolution Wealth Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-96
Closed -$5K 355
2021
Q3
$5K Sell
96
-145
-60% -$7.91K ﹤0.01% 511
2021
Q2
$13K Sell
241
-39
-14% -$2.08K ﹤0.01% 364
2021
Q1
$13K Hold
280
﹤0.01% 371
2020
Q4
$12K Buy
+280
New +$10.3K ﹤0.01% 327

Other funds holding HCAT

Evolution Wealth Advisors's HCAT Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 96 shares — an estimated $5K sold.

Evolution Wealth Advisors first reported a position in HCAT in Q4 2020 and held it in 4 quarters. The position peaked at $13K in Q2 2021. 187 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 96 Health Catalyst shares in Q4 2021, an estimated $5K.
  • Evolution Wealth Advisors first reported a position in Health Catalyst in Q4 2020 and held it in 4 quarters.
  • Evolution Wealth Advisors's Health Catalyst position peaked at $13K in Q2 2021.
  • 187 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.